All Stories

  1. Retinal vessel multifractals predict pial collateral status in patients with acute ischemic stroke
  2. Artificial Intelligence–Based Classification of Diabetic Peripheral Neuropathy From Corneal Confocal Microscopy Images
  3. Diagnosis of Neuropathy and Risk Factors for Corneal Nerve Loss in Type 1 and Type 2 Diabetes: A Corneal Confocal Microscopy Study
  4. Corneal Nerve and Brain Imaging in Mild Cognitive Impairment and Dementia
  5. Corneal confocal microscopy demonstrates minimal evidence of distal neuropathy in children with celiac disease
  6. Corneal confocal microscopy identifies greater corneal nerve damage in patients with a recurrent compared to first ischemic stroke
  7. Cornea: A Window to White Matter Changes in Stroke; Corneal Confocal Microscopy a Surrogate Marker for the Presence and Severity of White Matter Hyperintensities in Ischemic Stroke
  8. Medical and surgical management of obesity and diabetes: what's new?
  9. Diabetic peripheral neuropathy in people with type 2 diabetes: too little too late
  10. Diabetic neuropathy: A focus on small fibres
  11. Corneal nerve and endothelial cell damage in patients with transient ischemic attack and minor ischemic stroke
  12. DMI is a differential diagnosis for longstanding diabetics with sudden unexplained lower limb pain.
  13. An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy
  14. Diagnosing and managing diabetic somatic and autonomic neuropathy
  15. Diabetic Neuropathy: New Insights to Early Diagnosis and Treatments
  16. Mirogabalin and emerging therapies for diabetic neuropathy
  17. A fully automated cell segmentation and morphometric parameter system for quantifying corneal endothelial cell morphology
  18. Risk Factors for Failure of Direct Current Cardioversion in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation
  19. Diagnosing Diabetic Neuropathy: Something Old, Something New
  20. Diagnostic capability of retinal thickness measures in diabetic peripheral neuropathy
  21. Presence of Peripheral Neuropathy Is Associated With Progressive Thinning of Retinal Nerve Fiber Layer in Type 1 Diabetes
  22. Corneal confocal microscopy is a rapid reproducible ophthalmic technique for quantifying corneal nerve abnormalities
  23. Corneal confocal microscopy best identifies the development and progression of neuropathy in patients with type 1 diabetes
  24. Corneal Confocal Microscopy: An Imaging Endpoint for Axonal Degeneration in Multiple Sclerosis
  25. Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy
  26. Longitudinal study of neuropathy, microangiopathy, and autophagy in sural nerve: Implications for diabetic neuropathy
  27. Corneal confocal microscopy in multiple sclerosis
  28. Use of Corneal Confocal Microscopy to Evaluate Small Nerve Fibers in Patients With Human Immunodeficiency Virus
  29. Optical coherence tomography predicts 4-year incident diabetic neuropathy
  30. Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from Patient and Physician Surveys
  31. Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain
  32. An Automatic Tool for Quantification of Nerve Fibers in Corneal Confocal Microscopy Images
  33. Small-fibre neuropathy in men with type 1 diabetes and erectile dysfunction: a cross-sectional study
  34. Melatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy
  35. Network topology of NaV1.7 mutations in sodium channel-related painful disorders
  36. Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy
  37. Altered walking strategy and increased unsteadiness in participants with impaired glucose tolerance and Type 2 diabetes relates to small-fibre neuropathy but not vitamin D deficiency
  38. Effects of Panretinal Laser Photocoagulation on the Corneal Nerve Plexus and Retinal Nerve Fiber Layer in Retinal Vein Occlusion
  39. Assessment of Corneal Sensation, Innervation and Retinal Nerve Fiber Layer in Patients Treated with Multiple Intravitreal Ranibizumab Injections
  40. COL6A5variants in familial neuropathic chronic itch
  41. Improvement in Neuropathy Specific Quality of Life in Patients with Diabetes after Vitamin D Supplementation
  42. Iodine-123 metaiodobenzylguanidine scintigraphy for the assessment of cardiac sympathetic innervation and the relationship with cardiac autonomic function in healthy adults using standardized methods
  43. Diabetic Neuropathy: A Position Statement by the American Diabetes Association
  44. Visual complications in diabetes mellitus: beyond retinopathy
  45. NerveCheck for the Detection of Sensory Loss and Neuropathic Pain in Diabetes
  46. The perception of affective touch in Parkinson's disease and its relation to small fibre neuropathy
  47. A rapid decline in corneal small fibers and occurrence of foot ulceration and Charcot foot
  48. A fully automatic nerve segmentation and morphometric parameter quantification system for early diagnosis of diabetic neuropathy in corneal images
  49. Abnormal Anterior Corneal Morphology in Diabetes Observed Using In Vivo Laser-scanning Confocal Microscopy
  50. Repeatability of Measuring Corneal Nerve Migration Rate in Individuals With and Without Diabetes
  51. Response to Comment on Almurdhi et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels. Diabetes Care 2016;39:441–447
  52. Secondary Stroke Prevention: Improving Diagnosis and Management with Newer Technologies
  53. Ethnic variation in acute cerebrovascular disease: Analysis from the Qatar stroke registry
  54. Subjects With Extreme-Duration Type 1 Diabetes Exhibit No Structural or Functional Abnormality on Cardiac MRI
  55. Diabetes mellitus in the Arab world
  56. Diabetic neuropathy and painful diabetic neuropathy in the Middle East and North Africa (MENA) region: Much work needs to be done
  57. Pancreatic islet cell transplantation as a treatment for brittle type 1 diabetes: A case report and review of the literature
  58. Distal lower limb strength is reduced in subjects with impaired glucose tolerance and is related to elevated intramuscular fat level and vitamin D deficiency
  59. Risk Factors Associated With Corneal Nerve Alteration in Type 1 Diabetes in the Absence of Neuropathy
  60. Development of a Novel Technique to Measure Corneal Nerve Migration Rate
  61. Diabetes Dyslipidemia
  62. Perioperative management of diabetes in elective patients: a region-wide audit † †This Article is accompanied by Editorial Aew049.
  63. Focal loss volume of ganglion cell complex in diabetic neuropathy
  64. Early Corneal Cellular and Nerve Fiber Pathology in Young Patients With Type 1 Diabetes Mellitus Identified Using Corneal Confocal Microscopy
  65. NerveCheck: An inexpensive quantitative sensory testing device for patients with diabetic neuropathy
  66. Vitamin D and Diabetic Complications: True or False Prophet?
  67. Retinal Tissue Thickness is Reduced in Diabetic Peripheral Neuropathy
  68. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels
  69. Diabetes Mellitus
  70. Adhesive capsulitis of the shoulder and diabetes: a meta-analysis of prevalence
  71. Retinal tissue thickness in type 1 and type 2 diabetes
  72. Vitamin D Deficiency Is Not Associated with Diabetic Retinopathy or Maculopathy
  73. Wherefore Art Thou, O Treatment for Diabetic Neuropathy?
  74. Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy
  75. Retinal thickness profile of individuals with diabetes
  76. Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study
  77. Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy
  78. Erratum. Small Fiber Neuropathy in Patients With Latent Autoimmune Diabetes in Adults. Diabetes Care 2015;38:e102–e103
  79. Effect of Extended‐Release Niacin on High‐Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin‐Treated Patients
  80. Burning through the pain: treatments for diabetic neuropathy
  81. Diagnosis and management of type 1 diabetes in adults: summary of updated NICE guidance
  82. Focused Tortuosity Definitions Based on Expert Clinical Assessment of Corneal Subbasal Nerves
  83. Can corneal confocal microscopy help in early detection of neuronal damage and cognitive dysfunction as a consequence of metabolic syndrome in schizophrenia?
  84. Utility of Assessing Nerve Morphology in Central Cornea Versus Whorl Area for Diagnosing Diabetic Peripheral Neuropathy
  85. Corneal confocal microscopy for the diagnosis of diabetic autonomic neuropathy
  86. Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk
  87. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
  88. Corneal Confocal Microscopy Identifies Small-Fiber Neuropathy in Subjects With Impaired Glucose Tolerance Who Develop Type 2 Diabetes
  89. Corneal Confocal Microscopy Detects Neuropathy in Patients with Type 1 Diabetes without Retinopathy or Microalbuminuria
  90. Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy
  91. Corneal Confocal Microscopy Predicts 4-Year Incident Peripheral Neuropathy in Type 1 Diabetes
  92. Automated Quantification of Neuropad Improves Its Diagnostic Ability in Patients with Diabetic Neuropathy
  93. Corneal Confocal Microscopy Shows an Improvement in Small-Fiber Neuropathy in Subjects With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Compared With Multiple Daily Injection: Table 1
  94. Medalists With Extreme Duration of Type 1 Diabetes Exhibit Only Mild Diastolic Dysfunction and Myocardial Fibrosis: Table 1
  95. Natural History of Corneal Nerve Morphology in Mild Neuropathy Associated With Type 1 Diabetes: Development of a Potential Measure of Diabetic Peripheral Neuropathy
  96. Treatment of painful diabetic neuropathy
  97. Impairment of High-Density Lipoprotein Resistance to Lipid Peroxidation and Adipose Tissue Inflammation in Obesity Complicated by Obstructive Sleep Apnea
  98. The Role of Sodium Channels in Painful Diabetic and Idiopathic Neuropathy
  99. Why are there no good treatments for diabetic neuropathy?
  100. The diagnostic accuracy of Neuropad®for assessing large and small fibre diabetic neuropathy
  101. Fully Automated, Semiautomated, and Manual Morphometric Analysis of Corneal Subbasal Nerve Plexus in Individuals With and Without Diabetes
  102. Corneal Confocal Microscopy Detects Neuropathy in Subjects With Impaired Glucose Tolerance: Figure 1
  103. Which Test for Diagnosing Early Human Diabetic Neuropathy?
  104. Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab)
  105. Molecular and pathological studies in the posterior interosseous nerve of diabetic and non-diabetic patients with carpal tunnel syndrome
  106. Standardizing corneal nerve fibre length for nerve tortuosity increases its association with measures of diabetic neuropathy
  107. Morphometric Stability of the Corneal Subbasal Nerve Plexus in Healthy Individuals: A 3-Year Longitudinal Study Using Corneal Confocal Microscopy
  108. Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): Study design and baseline characteristics
  109. Rapid Automated Diagnosis of Diabetic Peripheral Neuropathy With In Vivo Corneal Confocal Microscopy
  110. Development and Validation of the QUT Corneal Nerve Grading Scale
  111. From the Bedside to the Bench and Back Again, With Corneal Confocal Microscopy
  112. Have we reached the limits for the treatment of diabetic nephropathy?
  113. ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 Diabetes
  114. Differential effects of different vitamin D replacement strategies in patients with diabetes
  115. Corneal nerve fibre damage precedes diabetic retinopathy in patients with Type 2 diabetes mellitus
  116. Corneal Confocal Microscopy to Assess Diabetic Neuropathy: An Eye on the Foot
  117. Evaluation of Contact Lens–Induced Changes in Keratoconic Corneas Using In Vivo Confocal Microscopy
  118. Corneal Nerve Loss Detected With Corneal Confocal Microscopy Is Symmetrical and Related to the Severity of Diabetic Polyneuropathy
  119. Medical strategies to reduce amputation in patients with Type 2 diabetes
  120. Effects of Bariatric Surgery on Human Small Artery Function
  121. Reply
  122. Repeatability of In Vivo Corneal Confocal Microscopy to Quantify Corneal Nerve Morphology
  123. A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy
  124. The acceptability and feasibility of corneal confocal microscopy to detect early diabetic neuropathy in children: a pilot study
  125. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis
  126. A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting
  127. Obesity, Diabetes and Atrial Fibrillation; Epidemiology, Mechanisms and Interventions
  128. Corneal Confocal Microscopy Detects Early Nerve Regeneration in Diabetic Neuropathy After Simultaneous Pancreas and Kidney Transplantation
  129. Corneal confocal microscopy detects small-fiber neuropathy in Charcot-Marie-Tooth disease type 1A patients
  130. Marked vitamin D deficiency in patients with diabetes in the UK: ethnic and seasonal differences and an association with dyslipidaemia
  131. Wide-Field Assessment of the Human Corneal Subbasal Nerve Plexus in Diabetic Neuropathy Using a Novel Mapping Technique
  132. Characteristics and Outcomes of Subjects With Diabetic Foot Ulceration
  133. Carotid intima–media thickness: ultrasound measurement, prognostic value and role in clinical practice
  134. Retinal nerve fibre layer thinning associated with diabetic peripheral neuropathy
  135. Are vitamin D and B deficiency relevant to the pathogenesis and treatment of diabetic neuropathy?
  136. Assessing corneal nerve structure and function in diabetic neuropathy
  137. Optimal Image Sample Size for Corneal Nerve Morphometry
  138. Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study
  139. Corneal sensitivity is related to established measures of diabetic peripheral neuropathy
  140. Effects of diabetes and hypertension on structure and distensibilty of human small coronary arteries
  141. Visual sensitivity loss in the central 30° of visual field is associated with diabetic peripheral neuropathy
  142. Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target
  143. Relationship of endothelial function and atherosclerosis to treatment response in late-life depression
  144. Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging
  145. Small fibre neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathy
  146. Small artery function 2 years postpartum in women with altered glycaemic distributions in their preceding pregnancy
  147. Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy
  148. Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.
  149. Reply to letter from Dr Zhivov and Dr Stachs
  150. Macrophage Activation Is Responsible for Loss of Anticontractile Function in Inflamed Perivascular Fat
  151. Increased Langerhan cell density and corneal nerve damage in diabetic patients: Role of immune mechanisms in human diabetic neuropathy
  152. Corneal Confocal Microscopy: A Novel Non-invasive Technique to Quantify Small Fibre Pathology in Peripheral Neuropathies
  153. Corneal Sensitivity as an Ophthalmic Marker of Diabetic Neuropathy
  154. Errata
  155. Cerebrovascular Damage in Late-Life Depression Is Associated With Structural and Functional Abnormalities of Subcutaneous Small Arteries
  156. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
  157. Repeatability of Measuring Corneal Subbasal Nerve Fiber Length in Individuals With Type 2 Diabetes
  158. Exploring retinal and functional markers of diabetic neuropathy
  159. Review: Novel insights on diagnosis, cause and treatment of diabetic neuropathy: focus on painful diabetic neuropathy
  160. Corneal confocal microscopy: A novel means to detect nerve fibre damage in idiopathic small fibre neuropathy
  161. Corneal Confocal Microscopy: A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy
  162. Explanations for the Lower Rates of Diabetic Neuropathy in Indian Asians Versus Europeans
  163. Neuropathy of Impaired Glucose Tolerance and Its Measurement
  164. Corneal confocal microscopy: A novel noninvasive means to diagnose neuropathy in patients with fabry disease
  165. Revascularization versus Medical Therapy for Renal-Artery Stenosis
  166. Eutrophic Remodeling of Small Arteries in Type 1 Diabetes Mellitus Is Enabled by Metabolic Control
  167. Mutational Analysis of CLC-5, Cofilin and CLC-4 in Patients with Dent’s Disease
  168. Diabetic cardiomyopathy – a distinct disease?
  169. Diabetic cardiomyopathy
  170. Local Inflammation and Hypoxia Abolish the Protective Anticontractile Properties of Perivascular Fat in Obese Patients
  171. Biopsy of the posterior interosseous nerve: a low morbidity method for assessment of peripheral nerve disorders
  172. Abnormal LDIflare but Normal Quantitative Sensory Testing and Dermal Nerve Fiber Density in Patients with Painful Diabetic Neuropathy
  173. Myogenic tone and small artery remodelling: insight into diabetic nephropathy
  174. Clinical applications of corneal confocal microscopy
  175. The Neuropad test: a visual indicator test for human diabetic neuropathy
  176. Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK
  177. Corneal Sensitivity Is Reduced and Relates to the Severity of Neuropathy in Patients With Diabetes: Response to Dash
  178. Reduced Vascular Endothelial Growth Factor Expression and Intra-Epidermal Nerve Fiber Loss in Human Diabetic Neuropathy
  179. Neurovascular Factors in Wound Healing in the Foot Skin of Type 2 Diabetic Subjects
  180. Corneal Confocal Microscopy Detects Early Nerve Regeneration After Pancreas Transplantation in Patients With Type 1 Diabetes
  181. Review: Microvascular complications: evaluation and monitoring relevance to clinical practice, clinical trials, and drug development
  182. Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy
  183. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
  184. Corneal Sensitivity Is Reduced and Relates to the Severity of Neuropathy in Patients With Diabetes
  185. Prospective randomized controlled study of Hydrofiber® dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers
  186. Technique of the Sural Nerve Biopsy
  187. Alstrom syndrome (OMIM 203800): a case report and literature review
  188. Ameliorating human diabetic neuropathy: Lessons from implanting hematopoietic mononuclear cells
  189. The Biogun: A Novel Way of Eradicating Methicillin-Resistant Staphylococcus Aureus Colonization in Diabetic Foot Ulcers: Response to Lipsky
  190. The Biogun: A novel way of eradicating methicillin-resistant Staphylococcus aureus colonization in diabetic foot ulcers
  191. Recent developments in the assessment of efficacy in clinical trials of diabetic neuropathy
  192. Early detection of diabetic peripheral neuropathy with corneal confocal microscopy
  193. Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy
  194. Diabetic Neuropathies: A statement by the American Diabetes Association
  195. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy
  196. Effects of Angiotensin Type-1 Receptor Antagonism on Small Artery Function in Patients With Type 2 Diabetes Mellitus
  197. Fasting and feasting safely during Ramadan in the patient with diabetes
  198. Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
  199. Diabetic Somatic Neuropathies
  200. Corneal Nerve Tortuosity in Diabetic Patients with Neuropathy
  201. Treatment of painful diabetic neuropathy: a review of the most efficacious pharmacological treatments
  202. Endoneurial Capillary Abnormalities Presage Deterioration of Glucose Tolerance and Accompany Peripheral Neuropathy in Man
  203. Current and Future Strategies for the Management of Diabetic Neuropathy
  204. Vascular Structural and Functional Changes in Type 2 Diabetes Mellitus
  205. Focal and multifocal neuropathies
  206. Commentary
  207. Nerve pathology in the type 1 diabetic dog: effects of treatment with sulindac
  208. Atrial flutter: the dangers of cardioversion
  209. Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology
  210. Clinico-pathological features of postural hypotension in diabetic autonomic neuropathy
  211. Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?
  212. Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes
  213. Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat
  214. Perineurial abnormalities in the spontaneously diabetic dog
  215. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial
  216. DIABETIC NEUROPATHY
  217. Relationship of elevated urinary albumin excretion to components of the metabolic syndrome in non-insulin-dependent diabetes mellitus
  218. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis)
  219. Response from the authors
  220. Mendenhall's syndrome: clues to the aetiology of human diabetic neuropathy.
  221. Vascular factors in diabetic neuropathy
  222. Vascular factors in diabetic neuropathy
  223. Cellular and humoral immunity in patients with insulin-dependent diabetes
  224. Endoneurial localisation of microvascular damage in human diabetic neuropathy
  225. Skin Epidermal Thickness and Vascular Density in Type 1 Diabetes
  226. Neutrophil Aldose Reductase Activity as a Potential Marker for Neuropathy and Cataract in Diabetes
  227. The Relationship Between Sural Nerve Morphometric Findings and Measures of Peripheral Nerve Function in Mild Diabetic Neuropathy
  228. Hypoxic neuropathy: relevance to human diabetic neuropathy
  229. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy
  230. Treatments Options
  231. Foot Ulceration and Charcot Arthropathy
  232. Pathophysiology of Diabetic Neuropathy
  233. Classification and Clinical Features of Neuropathy
  234. Detection/Screening/Assessment
  235. Epidemiology and Natural History of DPN
  236. Management Guidelines for Diabetic Peripheral Neuropathy and Foot Ulceration